Tolero Pharmaceuticals collaborates with AbbVie for AML trial

Clinical Research |  News | 0 Comment | 20 Aug, 2018

Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologic and oncologic diseases, has entered into a clinical research collab...Read more

HSA approves TCR immunotherapy trial for liver cancer

Clinical Research |  News | 0 Comment | 20 Aug, 2018

Lion TCR Pte. Ltd., a Singapore-based Biotech company has received approval from Health Sciences Authority (HSA), Singapore, for its Phase I/II multi-centre clinical study of its product ca...Read more

FSD Pharma, SciCann Launch clinical research program in Israel

Clinical Research |  News | 0 Comment | 17 Aug, 2018

FSD Pharma announced the launch of a clinical research collaborative program in Israel, via its strategic R&D partner, SciCann Therapeutics Inc. This comprehensive clinical resear...Read more

Kyowa Hakko Kirin announces results of Phase 3 trial of patients with Cutaneous T-cell Lymphoma

Clinical Research |  News | 0 Comment | 13 Aug, 2018

Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) investigating the use ...Read more

Ascletis’ Ganovo achieves top clinical research award

Clinical Research |  News | 0 Comment | 01 Aug, 2018

Ascletis announced that the Ganovo phase III clinical study won the top clinical research award at the 15th National Congress of Chinese Society of the Infectious Disease of the China Medic...Read more

Immunomedics announces multiple collaborations with cancer research institutions

Clinical Research |  News | 0 Comment | 30 Jul, 2018

 Singapore- Immunomedics, a biopharmaceutical company in the area of antibody-drug conjugates (ADC), announced a collaboration with the Yale Cancer Center at the Yale University School...Read more

SanBio Receives $20 Million Grant From CIRM

Clinical Research |  News | 0 Comment | 30 Jul, 2018

SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, has announced that it has been awarded a $20 million grant from the California Institute of Regenerati...Read more

Merck’s formulation steps further for approval in 21 EU countries

Clinical Research |  News | 0 Comment | 26 Jul, 2018

Singapore- Merck, a leading science and technology company, announced that the German Federal Institute for Drugs and Medical Devices has recommended to approve Merck's new formulation of E...Read more

Innovent receives IND approval to initiate Clinical Trials in China

Clinical Research |  News | 0 Comment | 26 Jul, 2018

Innovent Biologics, a world-class China-based biopharmaceutical company that develops and intends to commercialize high quality innovative antibody-based therapeutics, today announced that ...Read more

Research reveals Beckman Coulter's Access hsTnI's diagnostic accuracy

Clinical Research |  News | 0 Comment | 25 Jul, 2018

A recent article in the Annals of Emergency Medicine reported on the diagnostic accuracy of the newly released Beckman Coulter Access hsTnI assay in expediting the emergency department (ED)...Read more

WuXi STA, Antengene ink strategic agreement

Clinical Research |  News | 0 Comment | 20 Jul, 2018

STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec, and Antengene Corporation, a biopharmaceutical company, recently announced a strategic partnership for the CMC development and man...Read more

Puma biotech collaborates with Strata Oncology

Clinical Research |  News | 0 Comment | 19 Jul, 2018

Puma Biotechnology, Inc., a biopharmaceutical company, and Strata Oncology, Inc., a precision oncology company, have entered into a collaborative agreement to accelerate patient enrollment ...Read more

Latest Data on Eisai's Alzheimer's disease to be presented at AAIC 2018

Clinical Research |  News | 0 Comment | 19 Jul, 2018

Eisai Co., Ltd. announces that a total of 13 presentations highlighting results from a Phase II clinical study (Study 201) of the anti-amyloid beta (Abeta) protofibril antibody BAN2401 and ...Read more

New ALS therapy in clinical trials

Clinical Research |  News | 0 Comment | 17 Jul, 2018

About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The invariably fatal disease kills the nerve cells that con...Read more

NCP invests in Firma Clinical Research

Clinical Research |  News | 0 Comment | 17 Jul, 2018

Northlane Capital Partners has announced that it has made an investment in Firma Clinical Research (“Firma”), a niche contract research organization providing services to the bi...Read more

HSA approves Novartis's Kisqali

Clinical Research |  News | 0 Comment | 16 Jul, 2018

The Health Sciences Authority has approved Novartis Kisqali (Ribociclib, LEE011), earlier this year as a first-line treatment option for postmenopausal women with hormone receptor positive,...Read more

Ground-breaking study to hasten regenerative medicine development

Clinical Research |  News | 0 Comment | 13 Jul, 2018

Singapore – Scientists from A*STAR’s Institute of Molecular & Cell Biology (IMCB) have discovered a key epigenetic protein H3.3 that would facilitate the engineering and con...Read more

Scientists connect tuberal nucleus with appetite and body weight

Clinical Research |  News | 0 Comment | 11 Jul, 2018

Singapore – Researchers at A*STAR’s Singapore Bioimaging Consortium (SBIC) have identified a new region of the mouse brain called the Tuberal Nucleus (TN), which affects appetit...Read more